(Q44104695)

English

Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials

scientific article published in July 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

author name string

Brian R Ramjattan

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Denis J G Callaghan

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Uwe Theiss

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1105-1116

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

[Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?]

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Micronised fenofibrate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Micronized fenofibrate: a new fibric acid hypolipidemic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980022-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)80022-4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

release_jxu2hffij5aodhvbskjxvdyp5y

1 reference

https://api.fatcat.wiki/v0/release/jxu2hffij5aodhvbskjxvdyp5y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44104695&oldid=2106627581"